Compound heterozygosity (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Compound heterozygosity" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

5doi.org

2^nd place

1uq.edu.au

3,558^th place

2,403^rd place

1web.archive.org

1^st place

1jbc.org

4,455^th place

5,199^th place

doi.org

KJ Allen; LC Gurrin; CC Constantine; et al. (2008-01-17). "Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis" (PDF). New England Journal of Medicine. 358 (3): 221–230. doi:10.1056/NEJMoa073286. PMID 18199861.
Deugnier Y, Mosser J (Aug 2008). "Modifying factors of the HFE hemochromatosis phenotype". Expert Review of Gastroenterology & Hepatology. 2 (4): 531–540. doi:10.1586/17474124.2.4.531. PMID 19072401.
Anderson JA, Fisch R, Miller E, Doeden D (Mar 1966). "Atypical phenylketonuric heterozygote. Deficiency in phenylalanine hydroxylase and transaminase activity". Journal of Pediatrics. 68 (3): 351–360. doi:10.1016/s0022-3476(66)80237-8. PMID 4379218.
Gonzalez-Redondo JM, Stoming TA, Lanclos KD, et al. (1988). "Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States". Blood. 72 (3): 1007–1014. doi:10.1182/blood.V72.3.1007.bloodjournal7231007. PMID 2458145.
Witkowska HE; Lubin BH; Beuzard Y; Baruchel S; Esseltine DW; Vichinsky EP; Kleman KM; Bardakdjian-Michau J; Pinkoski L; Cahn S; et al. (1991-10-17). "Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori". New England Journal of Medicine. 325 (16). Massachusetts Medical Society: 1150–1154. doi:10.1056/NEJM199110173251607. PMID 1891024.

jbc.org

Ohno, Kousaku & Suzuki, Kunihiko (1988-12-05). "Multiple Abnormal beta-Hexosaminidase alpha-Chain mRNAs in a Compound-Heterozygous Ashkenazi Jewish Patient with Tay–Sachs Disease" (PDF). Journal of Biological Chemistry. 263 (34): 18563–7. PMID 2973464. Archived from the original (PDF) on 2007-09-26. Retrieved 2007-05-11.

nih.gov

pubmed.ncbi.nlm.nih.gov

KJ Allen; LC Gurrin; CC Constantine; et al. (2008-01-17). "Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis" (PDF). New England Journal of Medicine. 358 (3): 221–230. doi:10.1056/NEJMoa073286. PMID 18199861.
Rossi E, Olynyk JK, Cullen DJ, Papadopoulos G, Bulsara M, Summerville L, Powell LW (Feb 2000). "Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women". Clinical Chemistry. 46 (2): 162–166. PMID 10657371.
Deugnier Y, Mosser J (Aug 2008). "Modifying factors of the HFE hemochromatosis phenotype". Expert Review of Gastroenterology & Hepatology. 2 (4): 531–540. doi:10.1586/17474124.2.4.531. PMID 19072401.
Anderson JA, Fisch R, Miller E, Doeden D (Mar 1966). "Atypical phenylketonuric heterozygote. Deficiency in phenylalanine hydroxylase and transaminase activity". Journal of Pediatrics. 68 (3): 351–360. doi:10.1016/s0022-3476(66)80237-8. PMID 4379218.
Avigad S, Kleiman S, Weinstein M, Cohen BE, Schwartz G, Woo SL, Shiloh Y (Aug 1991). "Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: The contribution of mutations for classical phenylketonuria". American Journal of Human Genetics. 49 (2): 393–399. PMC 1683284. PMID 1867197.
Ohno, Kousaku & Suzuki, Kunihiko (1988-12-05). "Multiple Abnormal beta-Hexosaminidase alpha-Chain mRNAs in a Compound-Heterozygous Ashkenazi Jewish Patient with Tay–Sachs Disease" (PDF). Journal of Biological Chemistry. 263 (34): 18563–7. PMID 2973464. Archived from the original (PDF) on 2007-09-26. Retrieved 2007-05-11.
Gonzalez-Redondo JM, Stoming TA, Lanclos KD, et al. (1988). "Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States". Blood. 72 (3): 1007–1014. doi:10.1182/blood.V72.3.1007.bloodjournal7231007. PMID 2458145.
Witkowska HE; Lubin BH; Beuzard Y; Baruchel S; Esseltine DW; Vichinsky EP; Kleman KM; Bardakdjian-Michau J; Pinkoski L; Cahn S; et al. (1991-10-17). "Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori". New England Journal of Medicine. 325 (16). Massachusetts Medical Society: 1150–1154. doi:10.1056/NEJM199110173251607. PMID 1891024.

ncbi.nlm.nih.gov

Avigad S, Kleiman S, Weinstein M, Cohen BE, Schwartz G, Woo SL, Shiloh Y (Aug 1991). "Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: The contribution of mutations for classical phenylketonuria". American Journal of Human Genetics. 49 (2): 393–399. PMC 1683284. PMID 1867197.

uq.edu.au

espace.library.uq.edu.au

KJ Allen; LC Gurrin; CC Constantine; et al. (2008-01-17). "Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis" (PDF). New England Journal of Medicine. 358 (3): 221–230. doi:10.1056/NEJMoa073286. PMID 18199861.

web.archive.org

Ohno, Kousaku & Suzuki, Kunihiko (1988-12-05). "Multiple Abnormal beta-Hexosaminidase alpha-Chain mRNAs in a Compound-Heterozygous Ashkenazi Jewish Patient with Tay–Sachs Disease" (PDF). Journal of Biological Chemistry. 263 (34): 18563–7. PMID 2973464. Archived from the original (PDF) on 2007-09-26. Retrieved 2007-05-11.